Various studies have reported the role of ROS in cancer, manifested by an increase in TBARS and PC and a reduction in the activity of SOD, GSH, and catalase (Tiwari et al., 2016; Al-Saeedan et al., 2018). The gene discussed is SOD1; the disease is cancer.